GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » Price-to-Funds-From-Operations

PHAR (Pharming Group) Price-to-Funds-From-Operations : (As of Dec. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pharming Group Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Pharming Group Business Description

Industry
Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.